Net debt/EBITDA společnosti QSAM Biosciences
Jaká je hodnota metriky Net debt/EBITDA společnosti QSAM Biosciences?
Hodnota metriky Net debt/EBITDA společnosti QSAM Biosciences, Inc. je 2.75
Jaká je definice metriky Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA společností v sektoru Health Care sektor na OTC ve srovnání se společností QSAM Biosciences
Čemu se věnuje společnost QSAM Biosciences?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Firmy s metrikou net debt/ebitda podobnou společnosti QSAM Biosciences
- Hodnota metriky Net debt/EBITDA společnosti International Housewares Retail je 2.75
- Hodnota metriky Net debt/EBITDA společnosti DGL je 2.75
- Hodnota metriky Net debt/EBITDA společnosti Novabay Pharmaceuticals Inc je 2.75
- Hodnota metriky Net debt/EBITDA společnosti Barksdale Capital je 2.75
- Hodnota metriky Net debt/EBITDA společnosti Braemar Shipping Services plc je 2.75
- Hodnota metriky Net debt/EBITDA společnosti Goldstream Investment je 2.75
- Hodnota metriky Net debt/EBITDA společnosti QSAM Biosciences je 2.75
- Hodnota metriky Net debt/EBITDA společnosti Nanoxplore Inc je 2.75
- Hodnota metriky Net debt/EBITDA společnosti DelMar Pharmaceuticals je 2.76
- Hodnota metriky Net debt/EBITDA společnosti Marathon Oil je 2.76
- Hodnota metriky Net debt/EBITDA společnosti Resmed je 2.76
- Hodnota metriky Net debt/EBITDA společnosti Zeotech je 2.76
- Hodnota metriky Net debt/EBITDA společnosti Southern Copper je 2.76